KFDA reviews foreign GMP facilities

Published: 2008-12-15 06:57:00

Updated: 2008-12-15 06:57:00

The Korea Food and Drug Administration has begun to review GMP facilities of Sandoz in India to ensure the generic quality of a lipid-lowering agent, a source said recently.

The administration launched a review group and conducted an on-the-spot inspection of Sandoz India.

So far, the KFDA ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK